Navigation Links
Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox
Date:7/13/2011

STEVENSVILLE, Md., July 13, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has received approval from the Medical Device Bureau of Health Canada for the Precision Flow® Heliox device which will be launched later this year in the Canadian hospital market. The device is part of Vapotherm's High Flow Specialty Gas Program.

"We are pleased to receive our license in Canada for Precision Flow® Heliox, the first high flow device specifically designed for heliox delivery, said Bill Niland, Chairman and Director of New Business Development at Vapotherm."  The Company has also submitted for 510(k) clearance of the device in the U.S. and is also submitting for CE marking for other international markets.  

Vapotherm's High Flow Specialty Gas Program was created to expand High Flow Therapy (HFT) beyond air and oxygen to other medical and specialty gases.  The Company's flagship platform device, the Precision Flow®, was developed with a modular design concept to allow for several specialty applications in neonatal, pediatric and adult patient populations.  In all applications, the device optimizes the delivery of gases via precise blending, flow control and temperature management.  As with all Vapotherm HFT products, the overall goal is non-invasive respiratory support via a simple nasal cannula in a device that is easy for clinicians to operate but comprehensive in terms of safety and performance features. The Company plans to announce additional modules in the coming weeks.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit www.vtherm.com.

Contact: Kevin Thibodeau, Executive Vice President of Sales and Marketing
410-604-3977


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device
2. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
3. Vapotherm Announces New Exclusive Distribution Agreement with Hippo Medical for South Korea
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)... 3, 2017  Agragen, LLC, a ... the biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces ... lead drug candidates, AGR131.  This drug is designed ... the blood of patients suffering from inflammatory conditions ... disease. Biological ...
(Date:8/2/2017)... MEMPHIS, Tenn. and BENTON, Ky. , Aug. 2, 2017 /PRNewswire/ ... new member to its environmental services (ES) team to proactively reduce the risk of hospital-acquired ... is a UV disinfection robot that uses UVC light energy to kill deadly pathogens such ... ... Tru-D ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... financial consultations to communities throughout the greater DC region, is inaugurating a “New ... of rescuing local animals and training them to be companions for veterans in ...
(Date:8/18/2017)... Plantation, FL (PRWEB) , ... August 18, 2017 ... ... asset protection and financial planning assistance that serves communities throughout southern Florida, is ... event to provide scholarship assets to children from low income families. , The ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Abilene, Texas (PRWEB) , ... August 18, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... that he says will lift the veil on false teachings pertaining to the mother of ... Holy Scriptures teach, you see a far different picture of the role of this historical ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... numbers and call tracking and monitoring solutions, announced today the launch of a ... include a modern navigation and aesthetic, fully responsive design, and an enhanced search ...
Breaking Medicine News(10 mins):